American Association For Cancer Research
Breast cancer researcher receives outstanding investigator award
SAN ANTONIO — Christina Curtis, PhD, MSc, received this year’s AACR Outstanding Investigator Award for Breast Cancer Research.
AACR report highlights dramatic improvement in outcomes for children, adolescents
The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.
‘Broader and more inclusive design’ needed for novel cancer trials
Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.
Money, marketing and inclusion needed to ‘eradicate that gap’ in health care disparities
Robert A. Winn, MD, FAACR, first called for celebration.
AACR report: Despite progress, disparities in cancer incidence, mortality persist
The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.
Feasibility of allogeneic CAR-T in solid tumors shown in advanced kidney cancer
Sumanta K. Pal, MD, FASCO, expressed a mix of emotions.
Educational video helps ‘empower’ Black men to take control of prostate cancer risk
A 10-minute video designed to educate Black men on prostate cancer risks prompted 93% of viewers to report they intend to be screened in the future, according to study results presented at American Association for Cancer Research Annual Meeting.
Next-generation PARP inhibitor shows clinical benefit in certain patients with breast cancer
Saruparib conferred clinically impactful treatment outcomes among adults with breast cancer who harbor certain genetic mutations, according to data presented at American Association for Cancer Research Annual Meeting.
AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer
An artificial intelligence-driven algorithm used a novel liquid biopsy assay to differentiate women with ovarian cancer from healthy patients, according to results presented at American Association for Cancer Research Annual Meeting.
AACR to honor Pfizer, Albert Bourla, PhD, for service to cancer science and medicine
Pfizer Inc. and its chairman/CEO, Albert Bourla, PhD, will be awarded the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine during the American Association for Cancer Research Annual Meeting in San Diego.